Clinical trial
Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast…
NCT00001507 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001507 |
|---|---|
| Title | Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer |
| Official title | A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide With Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasm, Neoplasm Metastasis |
| Intervention type | Device, Drug |
| Interventions | Monoclonal Antibody 3A1, Monoclonal Antibody 95-5-49, Monoclonal Antibody 95-6-22, Baxter Isolex 3001 Stem Cell Selection System, Ceprate SC |
| Enrollment | 107 |
| Start date | Jul 12, 1996 |
| Primary completion | Jun 30, 1998 |
| Completion | Jun 20, 2014 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 21, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: